ATX vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ATX

AMPLIA FPO [ATX]

56MEDIUM

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

ATX EYE
Technical
52
46
Catalyst
50
54
Sentiment
50
50
Fundamental
68
60
Momentum
62
65
Risk Gate
50
50

Key Metrics

ATX Metric EYE
$69.3MMarket Cap$38.5M
779KAvg Volume (20d)199K
+0.0%Short InterestN/A
$0.27552-Week High$0.205
$0.10052-Week Low$0.100
+0.0%Daily Change+3.8%
$0.135Reference Price$0.135
-25.5%ROE-26.1%
-160.9%Profit Margin-12.4%

Active Signals

ATX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 6.9% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (13 quarters)

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

Ask Scout AI to compare ATX and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs EYE →CMP vs RHT →EYE vs IIQ →EYE vs LDX →EYE vs LGP →
ATX Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).